
- 积分
- 2113
- 威望
- 2113
- 包包
- 11684
|

1 r! I! W/ o9 h7 f* T+ v
& P* @ P1 Z+ }5 `
! A( v$ m. T% j l3 d& C4 ~: \0 k! @1 {
& B+ w3 k. ~3 l; ]$ @4 S2 c
" N, {+ f% X" l3 s+ j$ Q
( \! X+ b9 W2 J7 c1 l7 d- Y0 ddoi:10.1016/j.ccr.2014.03.036. I' a' g" _" F) V a x
PMC:
+ _( C) H5 d: ~3 O* h; c PMID:
" [' @: b" Q' N2 n) e
* h3 ~: ~% H7 H* X& L3 v; e; P ~1 s
* h5 A. N" y2 xMyelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
' F' O( L& T, s " [5 Q" J* Q; w, a
Petter S. Woll, Una Kj?llquist, Onima Chowdhury, Helen Doolittle, David C. Wedge, Supat Thongjuea, Rikard Erlandsson, Mtakai Ngara, Kristina Anderson,.et al.
5 Y, h1 d( Q/ e+ n9 w. s
# Z8 {* n$ B: WEvidence for distinct human cancer stem cells (CSCs) remains contentious and the degree to which different cancer cells contribute to propagating malignancies in patients remains unexplored. In low- to intermediate-risk myelodysplastic syndromes (MDS), we establish the existence of rare multipotent MDS stem cells (MDS-SCs), and their hierarchical relationship to lineage-restricted MDS progenitors. All identified somatically acquired genetic lesions were backtracked to distinct MDS-SCs, establishing their distinct MDS-propagating function in vivo. In isolated del(5q)-MDS, acquisition of del(5q) preceded diverse recurrent driver mutations. Sequential analysis in del(5q)-MDS revealed genetic evolution in MDS-SCs and MDS-progenitors prior to leukemic transformation. These findings provide definitive evidence for rare human MDS-SCs in vivo, with extensive implications for the targeting of the cells required and sufficient for MDS-propagation.* a5 x: \- _' L4 S1 a f# }5 w
0 h u) t! l* q# Q& z # N- Q2 I6 C; A* [- z- z
|
|